Charles River Newsroom

Charles River Analyst Ratings

BenzingaOct 23 18:47

Barclays Maintains Charles River(CRL.US) With Hold Rating, Maintains Target Price $205

Futu NewsOct 16 17:31

J.P. Morgan Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $195

Futu NewsOct 15 20:36

Analysts Conflicted on These Healthcare Names: Penumbra (PEN), Nurix Therapeutics (NRIX) and Charles River Labs (CRL)

TipRanksOct 15 20:15

Barclays Maintains Charles River(CRL.US) With Hold Rating, Cuts Target Price to $205

Futu NewsOct 15 19:31

Redburn Atlantic Initiates Coverage On Charles River With Sell Rating, Announces Price Target of $151

BenzingaOct 15 00:15

Charles River Analyst Ratings

BenzingaOct 15 00:14

Goldman Sachs Adjusts Price Target on Charles River Laboratories International to $240 From $250, Maintains Buy Rating

MT NewswiresOct 8 21:53

Charles River Labs Price Target Cut to $190.00/Share From $225.00 by Evercore ISI Group

Dow JonesOct 7 19:51

Charles River Analyst Ratings

BenzingaOct 7 19:42

Evercore Downgrades Charles River(CRL.US) to Hold Rating

Futu NewsOct 7 18:32

Evercore ISI Downgrades Charles River Labs (CRL) to a Hold

TipRanksOct 7 18:29

BofA Securities Downgrades Charles River(CRL.US) to Hold Rating, Cuts Target Price to $215

Futu NewsOct 2 22:31

Charles River Labs Cut to Neutral From Buy by B of A Securities

Dow JonesOct 2 19:32

BofA Securities Downgrades Charles River(CRL.US) to Hold Rating, Cuts Target Price to $215

Futu NewsOct 2 18:31

Bio-Rad Upped by Citi to Buy; Charles River, Hologic Downgraded

Seeking AlphaOct 2 06:38

Charles River Analyst Ratings

BenzingaOct 1 21:30

Citi Downgrades Charles River(CRL.US) to Sell Rating, Cuts Target Price to $175

Futu NewsOct 1 18:31

Evercore Maintains Charles River(CRL.US) With Buy Rating, Maintains Target Price $225

Futu NewsSep 25 20:31

Evercore ISI Sticks to Their Buy Rating for Charles River Labs (CRL)

TipRanksSep 25 20:23